Back to search results

Continuous Glucose Monitors for Children and Adolescents with Obesity

This study is looking at whether continuous glucose monitors (CGMs) are practical for children and adolescents with obesity. CGMs are devices that measure your blood sugar levels every five minutes. The study wants to see if using a CGM can help young people with obesity make positive changes to their eating and activity levels. You might be able to join if you are between 10 and 21 years old and have obesity (BMI above the 95th percentile). The study aims to enroll 30 participants and will measure how easy it is to recruit people, keep them in the study, and if they stick with using the CGM over 6 weeks. The current recruitment status is unclear.

Study design
This is an interventional, crossover feasibility trial involving 30 participants. Participants will be randomly assigned to either a blinded or unblinded CGM group for three weeks, then switch to the other group for another three weeks.
What's involved
You would use a continuous glucose monitor for a total of six weeks, switching between a blinded and unblinded period.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoints are measured at 6 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06254768

Use of Continuous Glucose Monitors in Children and Adolescents With Obesity

Recruiting
NAAges 10–21InterventionalPrevention
University of California, Los Angeles
~30 participants
Updated 2024-02-12 on ClinicalTrials.gov
What's tested:Continuous glucose monitor

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility of continuous glucose monitor(CGM) use in children and adolescents with obesity
Measured over 6 weeks

Conditions

Pediatric Obesity

Explore related trials

Obesity

Where it's being run

1 sites across 1 states
California1

Study leadership

  • Steven D Mittelman, MD, PhD · STUDY_DIRECTOR · University of California, Los Angeles

Who to contact

Sri Nikhita Chimatapu, MD
[email protected]
9177414080
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 10-21 years BMI \>95th percentile

Exclusion

Previous diagnosis of Prader Willi Syndrome or hypothalamic obesity
Intellectual disability
Previous or planned bariatric surgery
Hemoglobin A1c \>6.5 %
Current use of medication that impacts weight

What this trial measures

  • Feasibility of continuous glucose monitor(CGM) use in children and adolescents with obesity6 weeks

    Investigator will measure this outcome using recruitment rate achieved each month for the duration of the study period as the number of participants screened per month over the number of participants consented.